FNAF 2 Movie: Roleplay vs Sonic 3 The Movie Obby: LEGACY
FNAF 2 Movie: Roleplay currently leads with 218 concurrent players against 144, a 1.5× advantage. On all-time peak the record belongs to FNAF 2 Movie: Roleplay at 322 concurrent players, versus 319. Lifetime, FNAF 2 Movie: Roleplay has more visits (18.1M vs 2.8M). Full side-by-side history for FNAF 2 Movie: Roleplay and Sonic 3 The Movie Obby: LEGACY is charted above.
FNAF 2 Movie: Roleplay
218
playing now
254 24h peak · 18.1M visits
VS
Sonic 3 The Movie Obby: LEGACY
144
playing now
175 24h peak · 2.8M visits
Player count history
FNAF 2 Movie: RoleplaySonic 3 The Movie Obby: LEGACY
Head to head
| Metric | FNAF 2 Movie: Roleplay | Sonic 3 The Movie Obby: LEGACY | Difference |
|---|---|---|---|
| Playing now | 218 | 144 | 74 (1.5×) |
| 24h peak | 254 | 175 | 79 |
| 24h average | 160 | 110 | 50 |
| 7-day peak | 291 | 287 | 4 |
| 7-day average | 163 | 134 | 29 |
| 30-day peak | 291 | 319 | 28 |
| All-time peak | 322 | 319 | 3 |
| 24h change | ▼ 18.4% | ▼ 22.0% | — |
| 7d change | — | — | — |
| Total visits | 18.1M | 2.8M | 15.3M (6.4×) |
| Visits (24h) | 23.9K | 24.3K | 356 |
| Visits (7d) | 179.4K | 109.7K | 69.7K (1.6×) |
| Favorites | 56.5K | 4.5K | 52K (12.6×) |
| Rating | 82.7% | 54.8% | — |
| Global rank (players) | #2,645 | #2,956 | of 5,938 |
| Trending score | -3.6 | -31.4 | — |
| Created | Jul 16, 2023 | Jan 28, 2025 | — |
| Genre | Roleplay & Avatar Sim | Obby & Platformer | — |
Other comparisons
FNAF 2 Movie: Roleplay vs NEW [FREE AVA + X5] MOUNT RANIERFNAF 2 Movie: Roleplay vs Giant Slap Troll TowerFNAF 2 Movie: Roleplay vs Budget BattlegroundsFNAF 2 Movie: Roleplay vs Goddess TycoonFNAF 2 Movie: Roleplay vs Cotton dreams towerFNAF 2 Movie: Roleplay vs Guess For Anime CardsCompare two other games →
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history — 8 days for FNAF 2 Movie: Roleplay, 5 for Sonic 3 The Movie Obby: LEGACY.